Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiangma Zhike Liquid is a Traditional Chinese Medicine (TCM) liquid formulation developed by Shenzhen Lirui Pharmaceutical Technology for the treatment of respiratory conditions. It is specifically indicated for cough associated with acute tracheobronchitis, particularly when categorized under the TCM syndrome of "wind-cold attacking the lung." The drug is a multi-component herbal extract designed to relieve cough symptoms and regulate lung Qi. It has been evaluated in a randomized, double-blind, placebo-controlled Phase II clinical trial (CTR20131344) in China to assess its efficacy and safety profile in patients with these symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jiangma Zhike Liquid.